CN103080336B - 检测胚胎或肿瘤染色体拷贝数的试剂盒、装置和方法 - Google Patents
检测胚胎或肿瘤染色体拷贝数的试剂盒、装置和方法 Download PDFInfo
- Publication number
- CN103080336B CN103080336B CN201180035510.7A CN201180035510A CN103080336B CN 103080336 B CN103080336 B CN 103080336B CN 201180035510 A CN201180035510 A CN 201180035510A CN 103080336 B CN103080336 B CN 103080336B
- Authority
- CN
- China
- Prior art keywords
- dna
- dna fragmentation
- chromosomal
- ratio
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 42
- 210000001161 mammalian embryo Anatomy 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title claims abstract description 39
- 210000000349 chromosome Anatomy 0.000 title claims abstract description 29
- 238000012163 sequencing technique Methods 0.000 claims abstract description 14
- 108020004414 DNA Proteins 0.000 claims description 227
- 238000006062 fragmentation reaction Methods 0.000 claims description 187
- 238000013467 fragmentation Methods 0.000 claims description 171
- 239000013611 chromosomal DNA Substances 0.000 claims description 120
- 210000002381 plasma Anatomy 0.000 claims description 78
- 230000002759 chromosomal effect Effects 0.000 claims description 42
- 230000008774 maternal effect Effects 0.000 claims description 41
- 238000001514 detection method Methods 0.000 claims description 29
- 230000001915 proofreading effect Effects 0.000 claims description 19
- 238000010186 staining Methods 0.000 claims description 18
- 238000012408 PCR amplification Methods 0.000 claims description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 abstract description 32
- 239000008280 blood Substances 0.000 abstract description 32
- 210000000601 blood cell Anatomy 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 32
- 239000003153 chemical reaction reagent Substances 0.000 description 27
- 238000003752 polymerase chain reaction Methods 0.000 description 21
- 210000001766 X chromosome Anatomy 0.000 description 17
- 238000012937 correction Methods 0.000 description 10
- 210000003677 hemocyte Anatomy 0.000 description 9
- 229940000351 hemocyte Drugs 0.000 description 9
- 230000002159 abnormal effect Effects 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 230000001605 fetal effect Effects 0.000 description 7
- 238000010606 normalization Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000002669 amniocentesis Methods 0.000 description 6
- 238000013016 damping Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000007400 DNA extraction Methods 0.000 description 5
- 208000036878 aneuploidy Diseases 0.000 description 5
- 231100001075 aneuploidy Toxicity 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 5
- 230000000869 mutational effect Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 102000012410 DNA Ligases Human genes 0.000 description 4
- 108010061982 DNA Ligases Proteins 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000000703 high-speed centrifugation Methods 0.000 description 4
- 230000005477 standard model Effects 0.000 description 4
- 238000001712 DNA sequencing Methods 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000007847 digital PCR Methods 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 201000010374 Down Syndrome Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000029749 Microtubule Human genes 0.000 description 2
- 108091022875 Microtubule Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 206010044688 Trisomy 21 Diseases 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 210000004688 microtubule Anatomy 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000001612 separation test Methods 0.000 description 2
- 229960004249 sodium acetate Drugs 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 206010067477 Cytogenetic abnormality Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 108010047956 Nucleosomes Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000011304 droplet digital PCR Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001623 nucleosome Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000588 tumorigenic Toxicity 0.000 description 1
- 230000000381 tumorigenic effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims (14)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2011/075037 WO2012162884A1 (zh) | 2011-05-31 | 2011-05-31 | 检测胚胎或肿瘤染色体拷贝数的试剂盒、装置和方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103080336A CN103080336A (zh) | 2013-05-01 |
CN103080336B true CN103080336B (zh) | 2014-06-04 |
Family
ID=47258277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180035510.7A Active CN103080336B (zh) | 2011-05-31 | 2011-05-31 | 检测胚胎或肿瘤染色体拷贝数的试剂盒、装置和方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9885080B2 (zh) |
EP (1) | EP2716766B1 (zh) |
JP (1) | JP5926795B2 (zh) |
CN (1) | CN103080336B (zh) |
DK (1) | DK2716766T3 (zh) |
ES (1) | ES2605372T3 (zh) |
HU (1) | HUE031239T2 (zh) |
PL (1) | PL2716766T3 (zh) |
PT (1) | PT2716766T (zh) |
RS (1) | RS55518B1 (zh) |
WO (1) | WO2012162884A1 (zh) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2425240A4 (en) | 2009-04-30 | 2012-12-12 | Good Start Genetics Inc | METHOD AND COMPOSITION FOR EVALUATING GENETIC MARKERS |
US9163281B2 (en) | 2010-12-23 | 2015-10-20 | Good Start Genetics, Inc. | Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction |
WO2012177792A2 (en) | 2011-06-24 | 2012-12-27 | Sequenom, Inc. | Methods and processes for non-invasive assessment of a genetic variation |
US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
US10196681B2 (en) | 2011-10-06 | 2019-02-05 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
WO2013052907A2 (en) | 2011-10-06 | 2013-04-11 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
EP2768983A4 (en) | 2011-10-17 | 2015-06-03 | Good Start Genetics Inc | METHODS OF IDENTIFYING MUTATIONS ASSOCIATED WITH DISEASES |
LT2805280T (lt) | 2012-01-20 | 2022-12-27 | Sequenom, Inc. | Diagnostikos būdai, kurie atsižvelgia į eksperimentines sąlygas |
US8209130B1 (en) | 2012-04-04 | 2012-06-26 | Good Start Genetics, Inc. | Sequence assembly |
US10227635B2 (en) | 2012-04-16 | 2019-03-12 | Molecular Loop Biosolutions, Llc | Capture reactions |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10497461B2 (en) | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
WO2014014497A1 (en) * | 2012-07-20 | 2014-01-23 | Verinata Health, Inc. | Detecting and classifying copy number variation in a cancer genome |
US10482994B2 (en) | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
WO2014152421A1 (en) | 2013-03-14 | 2014-09-25 | Good Start Genetics, Inc. | Methods for analyzing nucleic acids |
LT2981921T (lt) | 2013-04-03 | 2023-02-27 | Sequenom, Inc. | Neinvazinio genetinių variacijų vertinimo būdai ir procesai |
IL309903A (en) | 2013-05-24 | 2024-03-01 | Sequenom Inc | Methods and processes for non-invasive evaluation of genetic variations |
KR102299305B1 (ko) | 2013-06-21 | 2021-09-06 | 시쿼넘, 인코포레이티드 | 유전적 변이의 비침습 평가를 위한 방법 및 프로세스 |
BR112016007401B1 (pt) | 2013-10-04 | 2023-04-11 | Sequenom, Inc. | Método para determinar a presença ou ausência de uma aneuploidia cromossômica em uma amostra |
CA2925111C (en) | 2013-10-07 | 2024-01-16 | Sequenom, Inc. | Methods and processes for non-invasive assessment of chromosome alterations |
US10851414B2 (en) | 2013-10-18 | 2020-12-01 | Good Start Genetics, Inc. | Methods for determining carrier status |
CA2928185C (en) | 2013-10-21 | 2024-01-30 | Verinata Health, Inc. | Method for improving the sensitivity of detection in determining copy number variations |
WO2015175530A1 (en) * | 2014-05-12 | 2015-11-19 | Gore Athurva | Methods for detecting aneuploidy |
US10318704B2 (en) | 2014-05-30 | 2019-06-11 | Verinata Health, Inc. | Detecting fetal sub-chromosomal aneuploidies |
AU2015267190B2 (en) * | 2014-05-30 | 2020-10-01 | Sequenom, Inc. | Chromosome representation determinations |
EP3760739A1 (en) | 2014-07-30 | 2021-01-06 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
WO2016040446A1 (en) | 2014-09-10 | 2016-03-17 | Good Start Genetics, Inc. | Methods for selectively suppressing non-target sequences |
CA2999708A1 (en) | 2014-09-24 | 2016-03-31 | Good Start Genetics, Inc. | Process control for increased robustness of genetic assays |
EP3567120B1 (en) | 2014-12-12 | 2020-08-19 | Verinata Health, Inc. | Using cell-free dna fragment size to determine copy number variations |
WO2016112073A1 (en) | 2015-01-06 | 2016-07-14 | Good Start Genetics, Inc. | Screening for structural variants |
US10095831B2 (en) | 2016-02-03 | 2018-10-09 | Verinata Health, Inc. | Using cell-free DNA fragment size to determine copy number variations |
EP3491560A1 (en) | 2016-07-27 | 2019-06-05 | Sequenom, Inc. | Genetic copy number alteration classifications |
US11694768B2 (en) | 2017-01-24 | 2023-07-04 | Sequenom, Inc. | Methods and processes for assessment of genetic variations |
CN107217308A (zh) * | 2017-06-21 | 2017-09-29 | 北京贝瑞和康生物技术股份有限公司 | 一种用于检测染色体拷贝数变异的测序文库构建方法和试剂盒 |
CN109112191A (zh) * | 2017-06-23 | 2019-01-01 | 沈阳精准医疗技术有限公司 | 一种肿瘤ctDNA的信息统计方法 |
CN109136363A (zh) * | 2018-08-31 | 2019-01-04 | 领航基因科技(杭州)有限公司 | 一种检测胎儿染色体非整数倍的试剂盒和检测胎儿甲基化dna拷贝数的方法 |
KR102532991B1 (ko) * | 2019-12-23 | 2023-05-18 | 주식회사 랩 지노믹스 | 태아의 염색체 이수성 검출방법 |
CN113096728B (zh) * | 2021-06-10 | 2021-08-20 | 臻和(北京)生物科技有限公司 | 一种微小残余病灶的检测方法、装置、存储介质及设备 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102108406A (zh) * | 2010-12-20 | 2011-06-29 | 北京贝瑞和康生物技术有限公司 | 检测胚胎染色体拷贝数的试剂盒、装置和方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE278035T1 (de) * | 1999-05-04 | 2004-10-15 | Ortho Clinical Diagnostics Inc | Schnelle und wirksame dns-immobilisierung aus einer probe ohne die verwendung von zelllysereagenzien |
US20100216153A1 (en) * | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
US20100112590A1 (en) | 2007-07-23 | 2010-05-06 | The Chinese University Of Hong Kong | Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment |
EP2952589B1 (en) | 2008-09-20 | 2018-02-14 | The Board of Trustees of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
ES2564656T3 (es) | 2009-10-26 | 2016-03-28 | Lifecodexx Ag | Medios y métodos para el diagnóstico no invasivo de la aneuploidía cromosómica |
CN102018406A (zh) | 2010-11-30 | 2011-04-20 | 赖新莲 | 一种治疗颈椎病的药枕 |
-
2011
- 2011-05-31 PT PT118669142T patent/PT2716766T/pt unknown
- 2011-05-31 JP JP2014513025A patent/JP5926795B2/ja active Active
- 2011-05-31 CN CN201180035510.7A patent/CN103080336B/zh active Active
- 2011-05-31 EP EP11866914.2A patent/EP2716766B1/en active Active
- 2011-05-31 PL PL11866914T patent/PL2716766T3/pl unknown
- 2011-05-31 WO PCT/CN2011/075037 patent/WO2012162884A1/zh active Application Filing
- 2011-05-31 RS RS20161036A patent/RS55518B1/sr unknown
- 2011-05-31 DK DK11866914.2T patent/DK2716766T3/da active
- 2011-05-31 ES ES11866914.2T patent/ES2605372T3/es active Active
- 2011-05-31 HU HUE11866914A patent/HUE031239T2/en unknown
- 2011-05-31 US US13/811,634 patent/US9885080B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102108406A (zh) * | 2010-12-20 | 2011-06-29 | 北京贝瑞和康生物技术有限公司 | 检测胚胎染色体拷贝数的试剂盒、装置和方法 |
Non-Patent Citations (4)
Title |
---|
《Analysis of the Size Distributions of Fetal and Maternal Cell-Free DNA by Paired-End Sequencing》;H. Christina Fan;《Clinical Chemistry》;20100617;第56卷(第8期);第1279-1286页 * |
《Maternal Plasma DNA Analysis with Massively Parallel Sequencing by Ligation for Noninvasive Prenatal Diagnosis of Trisomy 21》;Rossa W.K.;《Clinical Chemistry》;20091221;第56卷(第3期);第459-463页 * |
H. Christina Fan.《Analysis of the Size Distributions of Fetal and Maternal Cell-Free DNA by Paired-End Sequencing》.《Clinical Chemistry》.2010,第56卷(第8期),1279-1286. |
Rossa W.K..《Maternal Plasma DNA Analysis with Massively Parallel Sequencing by Ligation for Noninvasive Prenatal Diagnosis of Trisomy 21》.《Clinical Chemistry》.2009,第56卷(第3期),459-463. |
Also Published As
Publication number | Publication date |
---|---|
JP5926795B2 (ja) | 2016-05-25 |
EP2716766A1 (en) | 2014-04-09 |
CN103080336A (zh) | 2013-05-01 |
PT2716766T (pt) | 2016-11-21 |
US20130130921A1 (en) | 2013-05-23 |
RS55518B1 (sr) | 2017-05-31 |
JP2014516541A (ja) | 2014-07-17 |
ES2605372T3 (es) | 2017-03-14 |
DK2716766T3 (da) | 2017-01-02 |
PL2716766T3 (pl) | 2017-09-29 |
HUE031239T2 (en) | 2017-07-28 |
EP2716766B1 (en) | 2016-09-28 |
EP2716766A4 (en) | 2014-11-26 |
WO2012162884A1 (zh) | 2012-12-06 |
US9885080B2 (en) | 2018-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103080336B (zh) | 检测胚胎或肿瘤染色体拷贝数的试剂盒、装置和方法 | |
JP7506408B2 (ja) | 血漿dnaの単分子配列決定 | |
CN102108406B (zh) | 检测胚胎染色体拷贝数的试剂盒、装置和方法 | |
CN103525939B (zh) | 无创检测胎儿染色体非整倍体的方法和系统 | |
CN110770838B (zh) | 用于确定体细胞突变克隆性的方法和系统 | |
CN104169929B (zh) | 用于确定胎儿是否存在性染色体数目异常的系统和装置 | |
CN105483229B (zh) | 一种检测胎儿染色体非整倍体的方法及系统 | |
WO2015054080A1 (en) | Methods and processes for non-invasive assessment of chromosome alterations | |
CN105063209A (zh) | 一种外泌体miRNA的定量检测方法 | |
CN105653898A (zh) | 一种基于大规模数据挖掘的癌症检测试剂盒及检测方法 | |
CN103984879B (zh) | 一种测定待测基因组区域表达水平的方法及系统 | |
Ma et al. | The analysis of ChIP-Seq data | |
CN106367512A (zh) | 一种鉴定样本中肿瘤负荷的方法和系统 | |
CN110229897A (zh) | Med12基因突变检测试剂盒及其应用 | |
CN105779435A (zh) | 试剂盒及其用途 | |
CN108949979A (zh) | 一种通过血液样本判断肺结节良恶性的方法 | |
WO2018149114A1 (zh) | 确定胎儿染色体中微缺失微重复的方法及设备 | |
Bybjerg-Grauholm et al. | RNA sequencing of archived neonatal dried blood spots | |
CN105779433A (zh) | 试剂盒及其用途 | |
CN114540488B (zh) | 一种用于高通量靶向测序检测肿瘤突变负荷的基因组合、检测装置、检测试剂盒及应用 | |
KR101907650B1 (ko) | 비침습적 태아 염색체 이수성 판별 방법 | |
WO2019129200A1 (zh) | 一种c位点提取方法及装置 | |
CN109321641A (zh) | 一种基于dna片段富集及测序技术的产前无创胎儿染色体检测系统 | |
Smith et al. | DraculR: A Web-Based Application for In Silico Haemolysis Detection in High-Throughput microRNA Sequencing Data. Genes 2023, 14, 448 | |
Yao et al. | CAPZA2 and TRIB1 genomes contribute to the pathogenesis of ankylosing spondylitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130501 Assignee: Auspicious and the health gene diagnosis Technology Co., Ltd. of Hangzhou shellfish Assignor: Beijing Berry Genomics Co., Ltd. Contract record no.: 2015990000958 Denomination of invention: Kits, devices and methods for detecting chromosome copy number of embryo or tumor Granted publication date: 20140604 License type: Common License Record date: 20151116 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 102206, No. 5, building 4, 8 life Garden Road, Changping District science and Technology Park, Beijing, 801 Patentee after: Beijing Berry Genomics Biotechnology Co., Ltd Address before: Room 2, floor 207, building C, Shuguang building, No. 5, Shun Tong Road, Chaoyang District, Beijing, China Patentee before: Beijing Berry Genomics Co., Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130501 Assignee: Chengdu Berry and Kang medical laboratory Co., Ltd. Assignor: Beijing Berry Genomics Biotechnology Co., Ltd Contract record no.: 2016990000383 Denomination of invention: Kits, devices and methods for detecting chromosome copy number of embryo or tumor Granted publication date: 20140604 License type: Common License Record date: 20160907 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 102200 Beijing Changping District Science and Technology Park Life Park Road, No. 4 Courtyard, No. 5 Building, 8th Floor, 801 Patentee after: Beijing Berry Genomics Co., Ltd. Address before: 102206 8th Floor 801, No. 5 Building, No. 4 Life Garden Road, Changping District Science Park, Beijing Patentee before: Beijing Berry Genomics Biotechnology Co., Ltd |